Higher Infused CD34+ Cell Dose Improves Survival In Patients Undergoing In Vivo T-Cell Depleted, but Not T-Cell Replete Peripheral Blood Hematopoietic Cell Transplant
Abraham S. Kanate(HonorHealth), Sayed Mehdi Hamadani(West Virginia University), Scot C. Remick(University Hospitals of Cleveland), Laura F. Gibson(West Virginia University), Michael Craig(Edith Cowan University), Jame Abraham(Cleveland Clinic), Salman Osman(West Virginia University), Pamela Bunner(West Virginia University), William Tse(University of Louisville), Aaron Cumpston(West Virginia University Hospitals), Gerry Hobbs(West Virginia University), Sonia Leadmon(West Virginia University)
Cited by 0
Related Papers
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity
|JAMA|2022|324
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
|Transplantation and Cellular Therapy|2020|278